Collaborative Centre for Genomic Cancer Medicine
Pioneering breakthroughs for people with cancer
Who we are
The University of Melbourne and Peter Mac have come together to harness the power of genomics and change the face of cancer care. We’re pushing the boundaries of discovery to find innovative new solutions so every Australian can benefit from the latest in cutting-edge cancer prevention, diagnosis, and treatment.
Working together, our goal is to improve the lives of people with cancer through equitable access to personalised treatment options and prevention strategies informed by the latest genomic tests and analysis.
What we do
Transforming cancer pathology
We’re driving innovation in technology and developing new ways to improve cancer diagnosis and screening – including tests that can detect tumours with a single drop of blood. Our goal is to ensure every Australian with cancer gets the right genomic tests and treatments tailored to fit their unique genetic blueprint.
Making genomics the standard of care
Genomics is a powerful tool. When it comes to cancer care, it should be used routinely. We’re supporting clinical trials and developing new protocols so people with cancer have equitable access to genomics, making its insights more affordable and effective.
Addressing precision medicine’s data dilemma
We’re building better data solutions, that will pave the way for future research translation and discovery. This includes ensuring the datasets we use to assess new treatments include people from all backgrounds, to truly personalise cancer medicine.
Improving access to precision cancer care
Our researchers are striving to understand the health economic forces that will facilitate access to precision medicine, so each individual has equal access no matter where they live, their financial situation or the type of cancer they have. We’re working alongside industry to make the case for publicly funded genomic tests and cancer-fighting drugs.
How we work together
Peter Mac and the University of Melbourne have a close relationship going back many decades, to when Sir Peter MacCallum was appointed Chair of Pathology in 1924.
As leaders in cancer and research we are excited to continue this legacy, joining forces to push the boundaries of cancer prevention, diagnosis, and treatment.
Our research
Championing precision oncology research and comprehensive cancer genome testing for underserved groups.